OpenURL Connection Search

Select item for more details and to access through your institution.

Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.
Published in:
Cancer Immunology, Immunotherapy, 2021, v. 70, n. 8, p. 2125, doi. 10.1007/s00262-021-02857-z
By:
- Zanker, Damien J.;
- Owen, Katie L.;
- Baschuk, Nikola;
- Spurling, Alex J.;
- Parker, Belinda S.
Publication type:
Article
Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone.
Published in:
EMBO Reports, 2020, v. 21, n. 6, p. 1, doi. 10.15252/embr.202050162
By:
- Owen, Katie L;
- Gearing, Linden J;
- Zanker, Damien J;
- Brockwell, Natasha K;
- Khoo, Weng Hua;
- Roden, Daniel L;
- Cmero, Marek;
- Mangiola, Stefano;
- Hong, Matthew K;
- Spurling, Alex J;
- McDonald, Michelle;
- Chan, Chia‐Ling;
- Pasam, Anupama;
- Lyons, Ruth J;
- Duivenvoorden, Hendrika M;
- Ryan, Andrew;
- Butler, Lisa M;
- Mariadason, John M;
- Giang Phan, Tri;
- Hayes, Vanessa M
Publication type:
Article
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
Published in:
NPJ Precision Oncology, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41698-019-0093-2
By:
- Brockwell, Natasha K.;
- Rautela, Jai;
- Owen, Katie L.;
- Gearing, Linden J.;
- Deb, Siddhartha;
- Harvey, Kate;
- Spurling, Alex;
- Zanker, Damien;
- Chan, Chia-Ling;
- Cumming, Helen E.;
- Deng, Niantao;
- Zakhour, Jasmine M.;
- Duivenvoorden, Hendrika M.;
- Robinson, Tina;
- Harris, Marion;
- White, Michelle;
- Fox, Jane;
- Ooi, Corinne;
- Kumar, Beena;
- Thomson, Jacqui
Publication type:
Article
Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer.
Published in:
Clinical & Translational Immunology, 2020, v. 9, n. 9, p. 1, doi. 10.1002/cti2.1177
By:
- Zanker, Damien J;
- Spurling, Alex J;
- Brockwell, Natasha K;
- Owen, Katie L;
- Zakhour, Jasmine M;
- Robinson, Tina;
- Duivenvoorden, Hendrika M;
- Hertzog, Paul J;
- Mullins, Stefanie R;
- Wilkinson, Robert W;
- Parker, Belinda S
Publication type:
Article

Found: 4

Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer.

Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone.

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.

Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer.